Inder Singh
Vascular Neurology · Neptune, NJNPI 1770733891
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 69.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $76,325 and has fallen 76.9% since, to $17,618 in 2025.
Across 119 payments — averaging $1003.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$83K
- AbbVie$17K
- Penumbra, Inc.$10K
- Medical Device Business Services, Inc.$6K
- Ischemaview, Inc.$2K
- Imperative Care, Inc$1K
- plus $2K from 9 others
Across 54 payments — averaging $4552.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$162K
- Ocular Therapeutix, Inc.$84K
- AbbVie$50
What the payments were for
- Consulting fees$37,57631%
- Speaking & faculty fees$62,90053%
- Travel & lodging$14,62912%
- Food & beverage$4,3044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 50 | $82,725 |
| AbbVie | 12 | $16,625 |
| Penumbra, Inc. | 9 | $9,799 |
| Medical Device Business Services, Inc. | 2 | $5,794 |
| Ischemaview, Inc. | 2 | $1,500 |
| Imperative Care, Inc | 9 | $1,029 |
| Microvention, Inc. | 9 | $580 |
| Johnson & Johnson | 6 | $497 |
| Medtronic(2 entities) | 10 | $362 |
| Balt USA, LLC | 3 | $232 |
| Rapid Medical Ltd | 1 | $138 |
| Stryker | 3 | $77 |
| Novartis | 1 | $18 |
| Terumo Medical Corporation | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Activase$63,910
- Cathflo Activase$18,095
- TNKase$18,095
- DURYSTA$12,400
- Smart Coil$9,453
- EMBOGUARD$5,794
- Penumbra Jet 7$516
- ZOOM REPERFUSION CATHETER$283
- EMBOTRAP II Revascularization Device$268
- AXIUM PRIMETM$156
- WEB$155
- STENT$149
- Azur CX Detachable$149
- WEB DETACHMENT CONTROLLER$149
- WEB Aneurysm Embolization System$149
- ZOOM 88-T LARGE DISTAL PLATFORM$146
- Imperative Care Zoom$139
- Imperative Care TracStar$139
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$138
- COMANECI 17$138
How this compares
Too few vascular neurology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Neptune
- Peter BarcasNeptune$10K
- Pratit PatelNeptune$3K
- Laura RisleyNeptune$3K
- Fred RinconCamden$85K
- Kevin CrutchfieldHackensack$19K
- Kiwon LeeSummit$7K
- John HannaSummit$3K
- Gerald FerenczToms River$2K
- Steven ShapiroLivingston$2K
- Paul KaiserLawrenceville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.